Ebos Group Limited, commonly referred to as Ebos, is a leading healthcare and pharmaceutical company headquartered in Australia. Established in 1922, Ebos has grown to become a prominent player in the industry, with significant operations across New Zealand and Australia. The company focuses on the distribution of medical supplies, pharmaceuticals, and healthcare products, catering to hospitals, pharmacies, and aged care facilities. Ebos is renowned for its extensive product range, which includes medical consumables, surgical instruments, and pharmacy services, all distinguished by their quality and reliability. With a strong market position, Ebos has achieved notable milestones, including strategic acquisitions that have expanded its reach and capabilities. As a trusted partner in the healthcare sector, Ebos continues to innovate and adapt, ensuring it meets the evolving needs of its customers.
How does Ebos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Ebos's score of 20 is lower than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, EBOS Group Limited reported significant carbon emissions from its operations in Australia, totalling approximately 2,796,000 kg CO2e for Scope 1 and 2 emissions. This included 475,000 kg CO2e from mobile combustion, 305,000 kg CO2e from fugitive emissions, and 94,000 kg CO2e from stationary combustion. Additionally, Scope 2 emissions were also reported at about 2,796,000 kg CO2e. For the same year, the company's global emissions were reported at approximately 3,530,000 kg CO2e for Scope 1 and 18,289,000 kg CO2e for Scope 2. The breakdown for Scope 1 included 678,000 kg CO2e from mobile combustion, 555,000 kg CO2e from fugitive emissions, and 374,000 kg CO2e from stationary combustion. In New Zealand, EBOS reported Scope 1 emissions of about 304,000 kg CO2e and Scope 2 emissions of approximately 840,000 kg CO2e in 2023. Despite these figures, EBOS has not disclosed any specific reduction targets or initiatives as part of its climate commitments. The company does not appear to have cascaded emissions data from a parent organisation, indicating that all reported figures are directly from EBOS Group Limited. Overall, while EBOS Group Limited has made strides in reporting its emissions, it currently lacks defined reduction targets or initiatives to mitigate its carbon footprint.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | - | 000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 12,556,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ebos has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
